Immunologic characteristics of the 35 patients
| . | . | Patients (%) . |
|---|---|---|
| CD4+ T lymphocyte subset | Normal pts/tested pts (%) Pts with low level/tested pts (%) | 2/35 (6%) 33/35 (94%) |
| CD8+ T lymphocyte subset | Normal pts/tested pts (%) Pts with high level/tested pts (%) Pts with low level/tested pts (%) | 18/35 (51%) 9/35 (26%) 8/35 (23%) |
| B lymphocyte subset | Normal pts/tested pts (%) Pts with low level/tested pts (%) | 19/24 (79%) 5/24 (21%) |
| NK lymphocyte subset | Normal pts/tested pts (%) Pts with low level/tested pts (%) | 9/12 (75%) 3/12 (25%) |
| T cell proliferation in response to mitogens | Normal pts/tested pts (%) | 35/35 (100%) |
| T cell proliferation in response to antigens | Normal pts/tested pts (%) | 0/35 (0%) |
| IgG levels | Normal pts/tested pts (%) Pts with low level/tested pts (%) | 5/32 (16%) 27/32 (84%) |
| IgA levels | Normal pts/tested pts (%) Pts with low level/tested pts (%) | 15/32 (47%) 17/32 (53%) |
| IgM levels | Normal pts/tested pts (%) Pts with high level/tested pts (%) Pts with low level/tested pts (%) | 8/32 (25%) 3/32 (9%) 21/32 (66%) |
| IgE levels | Normal pts/tested pts (%) Pts with high level/tested pts (%) | 4/6 (67%) 2/6 (33%) |
| Specific antibodies against protein antigens (tetanus, diphtheria or polio) | Pts with low level/tested pts (%) | 20/20 (100%) |
| Antibody against S pneumonia | Normal pts/tested pts (%) Pts with abnormal response/tested pts (%) | 3/5(60%) 2/5(40%) |
| Allohemagglutinin | Normal pts/tested pts (%) Pts with low level/tested pts (%) | 3/5(60%) 2/5(40%) |
| . | . | Patients (%) . |
|---|---|---|
| CD4+ T lymphocyte subset | Normal pts/tested pts (%) Pts with low level/tested pts (%) | 2/35 (6%) 33/35 (94%) |
| CD8+ T lymphocyte subset | Normal pts/tested pts (%) Pts with high level/tested pts (%) Pts with low level/tested pts (%) | 18/35 (51%) 9/35 (26%) 8/35 (23%) |
| B lymphocyte subset | Normal pts/tested pts (%) Pts with low level/tested pts (%) | 19/24 (79%) 5/24 (21%) |
| NK lymphocyte subset | Normal pts/tested pts (%) Pts with low level/tested pts (%) | 9/12 (75%) 3/12 (25%) |
| T cell proliferation in response to mitogens | Normal pts/tested pts (%) | 35/35 (100%) |
| T cell proliferation in response to antigens | Normal pts/tested pts (%) | 0/35 (0%) |
| IgG levels | Normal pts/tested pts (%) Pts with low level/tested pts (%) | 5/32 (16%) 27/32 (84%) |
| IgA levels | Normal pts/tested pts (%) Pts with low level/tested pts (%) | 15/32 (47%) 17/32 (53%) |
| IgM levels | Normal pts/tested pts (%) Pts with high level/tested pts (%) Pts with low level/tested pts (%) | 8/32 (25%) 3/32 (9%) 21/32 (66%) |
| IgE levels | Normal pts/tested pts (%) Pts with high level/tested pts (%) | 4/6 (67%) 2/6 (33%) |
| Specific antibodies against protein antigens (tetanus, diphtheria or polio) | Pts with low level/tested pts (%) | 20/20 (100%) |
| Antibody against S pneumonia | Normal pts/tested pts (%) Pts with abnormal response/tested pts (%) | 3/5(60%) 2/5(40%) |
| Allohemagglutinin | Normal pts/tested pts (%) Pts with low level/tested pts (%) | 3/5(60%) 2/5(40%) |